Cargando…
Are SGLT2 polymorphisms linked to diabetes mellitus and cardiovascular disease? Prospective study and meta-analysis
Inhibition of the sodium glucose co-transporter 2 (SGLT2) reduces cardiovascular morbidity, and mortality in patients with type 2 diabetes mellitus (T2DM) with atherosclerotic, cardiovascular disease. So far, a link between common genetic variations of the SGLT2 encoding gene SLC5A2 and glucose home...
Autores principales: | Drexel, Heinz, Leiherer, Andreas, Saely, Christoph H., Brandtner, Eva Maria, Geiger, Kathrin, Vonbank, Alexander, Fraunberger, Peter, Muendlein, Axel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684948/ https://www.ncbi.nlm.nih.gov/pubmed/30988077 http://dx.doi.org/10.1042/BSR20190299 |
Ejemplares similares
-
Data on the association between CTRP1 and future major adverse cardiovascular events in patients undergoing coronary angiography
por: Muendlein, Axel, et al.
Publicado: (2019) -
Data on the power of the creatinine to uromodulin ratio in serum to predict cardiovascular events in coronary patients
por: Leiherer, Andreas, et al.
Publicado: (2017) -
Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography
por: Muendlein, Axel, et al.
Publicado: (2022) -
Genome-Wide Association Study Reveals a Polymorphism in the Podocyte Receptor RANK for the Decline of Renal Function in Coronary Patients
por: Leiherer, Andreas, et al.
Publicado: (2014) -
Data on the power of high betatrophin to predict cardiovascular deaths in coronary patients
por: Leiherer, Andreas, et al.
Publicado: (2019)